Literature DB >> 35574162

Optic Neuropathy Revealing Severe Superficial Siderosis in the Setting of Long-standing Low-grade Intracranial Neoplasm.

Coralie Hemptinne1, Adrienne Coche1, Thierry Duprez2, Philippe Demaerel3, Christian Raftopoulos4, Antonella Boschi1.   

Abstract

Two cases of optic neuropathy due to superficial siderosis (SS) are reported in two patients, aged 29 and 38 years, operated for intracranial neoplasms, the first one with a desmoplasic infantile ganglioglioma excised in 1991, and the other one with a pilocytic astrocytoma, operated on in 1997, 1998 and 2016. Both patients presented with progressive loss of visual acuity, as a result of bilateral optic nerve atrophy, as well as unsteadiness, ataxic gait and hearing loss. Magnetic resonance imaging (MRI) of the brain and spine, including gradient echo (GRE) T2-weighted acquisitions, revealed thin optic nerves and strong hypointensity with susceptibility artefacts corresponding to haemosiderin deposits within the meningeal layers of the spine, the infra- and supratentorial spaces of the brain and the peri-optic sheaths in both patients. The cerebrospinal fluid (CSF) was macroscopically haemorrhagic in one patient, who underwent a dynamic myelography, which failed to reveal any trans-dural CSF leakage. Neuro-ophthalmological symptoms due to SS, such as visual acuity loss, have been scarcely reported. MRI using GRE T2-weighted sequences highlighting the presence of haemosiderin deposits plays a key role in the diagnosis of this condition. Treatment should aim at preventing haemosiderin deposition by treating the cause of the subarachnoid bleeding.
© 2021 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Neuro-imaging; optic neuropathy; tumours

Year:  2021        PMID: 35574162      PMCID: PMC9103260          DOI: 10.1080/01658107.2021.1958870

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  12 in total

Review 1.  Superficial siderosis: a case report and review of the literature.

Authors:  Michael Levy; Christine Turtzo; Rafael H Llinas
Journal:  Nat Clin Pract Neurol       Date:  2007-01

2.  The value of gadolinium-chelates enhancement in neuroradiology.

Authors:  G Cosnard; T Duprez; T Munier
Journal:  J Belge Radiol       Date:  1997-02

3.  Optic neuropathy in superficial intracranial siderosis.

Authors:  Sally L Painter; Liberty Mathew; Gerardine Quaghebeur; Margaret M Esiri; John S Elston
Journal:  J Neuroophthalmol       Date:  2010-12       Impact factor: 3.042

4.  Superficial siderosis of the central nervous system: a 70-year-old man with ataxia, depression and visual deficits.

Authors:  M C Polidori; G Pelliccioli; M Catani; G Finali; U Senin; P Mecocci
Journal:  Gerontology       Date:  2001 Mar-Apr       Impact factor: 5.140

5.  Superficial siderosis and episodic fourth nerve paresis. Report of a case with clinical and magnetic resonance imaging findings.

Authors:  M Hashimoto; W F Hoyt
Journal:  J Neuroophthalmol       Date:  1996-12       Impact factor: 3.042

6.  The pathology of superficial siderosis of the central nervous system.

Authors:  Arnulf H Koeppen; Susan C Michael; Danhong Li; Zewu Chen; Matthew J Cusack; Walter M Gibson; Simone V Petrocine; Jiang Qian
Journal:  Acta Neuropathol       Date:  2008-08-12       Impact factor: 17.088

7.  Superficial hemosiderosis of the central nervous system.

Authors:  Y River; S Honigman; J M Gomori; A Reches
Journal:  Mov Disord       Date:  1994-09       Impact factor: 10.338

8.  Superficial siderosis of the central nervous system: a late complication of cerebellar tumors.

Authors:  N E Anderson; S Sheffield; J K Hope
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

Review 9.  Superficial siderosis of the central nervous system.

Authors:  J M Fearnley; J M Stevens; P Rudge
Journal:  Brain       Date:  1995-08       Impact factor: 13.501

10.  Secondary intracranial hypertension with acute intracranial pressure crisis in superficial siderosis.

Authors:  Stefan Linder; Dennis A Nowak; Sven-Olaf Rodiek; Christianto Lumenta; Helge Topka
Journal:  J Clin Neurosci       Date:  2008-07-23       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.